Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC-ESTRO OligoCare consortium.
Kroeze SGC, Pavic M, Stellamans K, Lievens Y, Becherini C, Scorsetti M, Alongi F, Ricardi U, Jereczek-Fossa BA, Westhoff P, But-Hadzic J, Widder J, Geets X, Bral S, Lambrecht M, Billiet C, Sirak I, Ramella S, Giovanni Battista I, Benavente S, Zapatero A, Romero F, Zilli T, Khanfir K, Hemmatazad H, de Bari B, Klass DN, Adnan S, Peulen H, Salinas Ramos J, Strijbos M, Popat S, Ost P, Guckenberger M. Kroeze SGC, et al. Among authors: bral s. Lancet Oncol. 2023 Mar;24(3):e121-e132. doi: 10.1016/S1470-2045(22)00752-5. Lancet Oncol. 2023. PMID: 36858728 Review.
Comparison of 6 MV and 18 MV photons for IMRT treatment of lung cancer.
Madani I, Vanderstraeten B, Bral S, Coghe M, De Gersem W, De Wagter C, Thierens H, De Neve W. Madani I, et al. Among authors: bral s. Radiother Oncol. 2007 Jan;82(1):63-9. doi: 10.1016/j.radonc.2006.11.016. Epub 2006 Dec 19. Radiother Oncol. 2007. PMID: 17182143
Phase II open-label study investigating apalutamide in patients with biochemical progression after radical prostatectomy.
Dirix P, Strijbos M, den Mooter TV, Liefhooghe N, Bruwaene SV, Uvin P, Ghysel C, Ost D, Schatteman P, Bral S, Engels B, den Begin RV, Otte FX, Roumeguere T, Palumbo S, Neybuch Y, Fonteyne V, Ost P, Dirix L. Dirix P, et al. Among authors: bral s. Future Oncol. 2020 Jun;16(16):1083-1189. doi: 10.2217/fon-2020-0056. Epub 2020 May 1. Future Oncol. 2020. PMID: 32356465
Urethra-Sparing Stereotactic Body Radiation Therapy for Prostate Cancer: Quality Assurance of a Randomized Phase 2 Trial.
Jaccard M, Zilli T, Dubouloz A, Escude L, Jorcano S, Linthout N, Bral S, Verbakel W, Bruynzeel A, Björkqvist M, Minn H, Tsvang L, Symon Z, Lencart J, Oliveira A, Ozen Z, Abacioglu U, Pérez-Moreno JM, Rubio C, Rouzaud M, Miralbell R. Jaccard M, et al. Among authors: bral s. Int J Radiat Oncol Biol Phys. 2020 Nov 15;108(4):1047-1054. doi: 10.1016/j.ijrobp.2020.06.002. Epub 2020 Jun 12. Int J Radiat Oncol Biol Phys. 2020. PMID: 32535161 Clinical Trial.
Every-Other-Day Versus Once-a-Week Urethra-Sparing Prostate Stereotactic Body Radiation Therapy: 5-Year Results of a Randomized Phase 2 Trial.
Zilli T, Jorcano S, Bral S, Symon Z, Rubio C, Bruynzeel AME, Ibrahimov R, Minn H, Oliveira A, Bertaut A, Constantin G, Miralbell R. Zilli T, et al. Among authors: bral s. Int J Radiat Oncol Biol Phys. 2023 Nov 15;117(4):791-798. doi: 10.1016/j.ijrobp.2023.03.057. Epub 2023 Mar 29. Int J Radiat Oncol Biol Phys. 2023. PMID: 37001763
Urethra-Sparing Prostate Cancer Stereotactic Body Radiation Therapy: Sexual Function and Radiation Dose to the Penile Bulb, the Crura, and the Internal Pudendal Arteries From a Randomized Phase 2 Trial.
Achard V, Zilli T, Lamanna G, Jorcano S, Bral S, Rubio C, Oliveira A, Bottero M, Bruynzeel AME, Ibrahimov R, Minn H, Symon Z, Constantin G, Miralbell R. Achard V, et al. Among authors: bral s. Int J Radiat Oncol Biol Phys. 2024 Jul 15;119(4):1137-1146. doi: 10.1016/j.ijrobp.2023.12.037. Epub 2023 Dec 29. Int J Radiat Oncol Biol Phys. 2024. PMID: 38160915 Free article. Clinical Trial.
25 results